查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1608950

螢光素酶檢測市場：依檢測法、按應用分類 - 2025-2030 年全球預測

Luciferase Assays Market by Method (Dual Reporter Assay, Flash Assay, Glow Assay), Application (Gene Expression, Metabolic Activity, Protein-Protein Interaction) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年螢光素酶檢測市值為15億美元，預計到2024年將達到16億美元，複合年成長率為7.03%，到2030年將達到24.2億美元。

螢光素酶測定是用於測量特定酶的存在或活性的生化測定，具有從基因表現研究到細胞活力評估的廣泛應用。這些測定利用了螢光素酶的發光能力，並已成為世界各地實驗室的重要工具。這種需求源於對生物過程敏感即時監測的需求，從而能夠快速篩檢化合物和途徑，特別是在藥物發現和藥物開發中。應用範圍廣泛，涵蓋製藥、生物技術、學術和臨床研究領域。最終用途包括醫療機構、實驗室和診斷中心。

主要市場統計
基準年[2023] 15億美元
預測年份 [2024] 16億美元
預測年份 [2030] 24.2億美元
複合年成長率（%） 7.03%

螢光素酶檢測市場受到幾個關鍵成長要素的影響，例如研發投資的增加、生物技術的創新以及需要先進診斷工具的慢性病盛行率的增加。最近的發展，例如訊號強度和穩定性提高的新型突變螢光素酶的開發，為市場參與者擴大其產品組合提供了重要機會。分析師建議利用與研究機構的合作，並投資於提高檢測靈敏度和即時資料分析的技術。

然而，市場成長面臨挑戰，例如檢測試劑套件和設備的高成本，以及與扭曲結果的背景發光干擾相關的潛在技術限制。必須透過研究具有成本效益的生產技術和改進檢測設計來解決這些限制。此外，針對最終用戶的高級檢測應用的持續教育和培訓計劃可以加速市場滲透。

業務成長的創新領域包括開發可以同時評估多個生物參數的多重螢光素酶檢測，以及與人工智慧主導的分析平台整合以提高解釋的速度和準確性。最後，該市場的特點是技術進步速度快，需要持續的研發努力以保持競爭優勢並滿足個人化醫療和高通量篩檢的新興需求。

市場動態：揭示快速發展的螢光素酶檢測市場的關鍵市場洞察

供需的動態交互作用正在改變螢光素酶檢測市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 擴大分子生物學和基因工程的應用
    • 開發即時定量可視化基因表現的技術
    • 擴大研究投資和政府支持
  • 市場限制因素
    • 產生發光需要分子氧
  • 市場機會
    • 飲料業微生物污染檢查的擴展應用
    • 玩家之間的策略聯盟
  • 市場挑戰
    • 相關技術問題

波特的五力螢光素酶測定是駕馭市場的策略工具

波特的五力框架是了解螢光素酶測定市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解螢光素酶檢測市場的外部影響

外部宏觀環境因素在塑造螢光素酶檢測市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解螢光素酶檢測市場的競爭格局

螢光素酶檢測市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣螢光素酶檢測市場供應商的績效評估

FPNV定位矩陣是評估螢光素酶檢測市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了螢光素酶檢測市場的成功之路

螢光素酶檢測市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 擴大分子生物學和基因工程的應用
      • 開發即時定量可視化基因表現的技術
      • 增加研究投入和政府支持
    • 抑制因素
      • 產生發光需要分子氧
    • 機會
      • 擴大用於飲料行業來檢查微生物污染
      • 玩家之間的戰略合作
    • 任務
      • 相關技術問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章螢光素酶檢測市場：依方法

  • 雙報告基因檢測
  • 快速測定
  • 發光分析
  • 單一報告基因檢測

第7章螢光素酶檢測市場：依應用分類

  • 基因表現
  • 代謝活動
  • 蛋白質-蛋白質相互作用
  • 轉譯後修飾

第8章美洲螢光素酶檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區螢光素酶檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲螢光素酶檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AAT Bioquest, Inc.
  • Abcam PLC
  • Active Motif, Inc.
  • Biotium
  • GeneCopoeia, Inc.
  • Gold Biotechnology
  • Invivogen
  • Lonza Group AG
  • Merck KGaA
  • Molecular Devices, LLC
  • Novus Biologicals
  • OriGene Technologies, Inc.
  • OZ Biosciences
  • Perkin Elmer, Inc.
  • Promega Corporation
  • PromoCell GmbH
  • SwitchGear Genomics, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-0302D35AB53D

The Luciferase Assays Market was valued at USD 1.50 billion in 2023, expected to reach USD 1.60 billion in 2024, and is projected to grow at a CAGR of 7.03%, to USD 2.42 billion by 2030.

Luciferase assays are biochemical analyses used to measure the presence or activity of specific enzymes, with applications ranging from gene expression studies to cell viability assessments. These assays capitalize on the luciferase enzyme's capability to produce luminescence, making them an indispensable tool in research laboratories globally. Their necessity arises from the demand for sensitive, real-time monitoring of biological processes, especially in drug discovery and development, where they facilitate rapid screening of compounds and pathways. The application scope is broad, encompassing pharmaceutical, biotech, academic, and clinical research sectors. End-use extends to healthcare institutions, research labs, and diagnostic centers.

KEY MARKET STATISTICS
Base Year [2023] USD 1.50 billion
Estimated Year [2024] USD 1.60 billion
Forecast Year [2030] USD 2.42 billion
CAGR (%) 7.03%

The market for luciferase assays is influenced by several key growth factors including the rise in R&D investments, innovations in biotechnology, and the increasing prevalence of chronic diseases necessitating advanced diagnostic tools. Recent advancements, such as the development of new mutant luciferases that enhance signal strength and stability, present significant opportunities for market players to expand their product offerings. Analysts recommend capitalizing on collaborations with research institutions and investing in technology to enhance assay sensitivity and real-time data analytics.

However, market growth faces challenges such as high costs of assay kits and equipment, and potential technical limitations involving background luminescence interference which can skew results. Addressing these limitations through research into cost-effective production techniques and improved assay designs is essential. Furthermore, continuous education and training programs for end-users on advanced assay applications can drive market penetration.

Innovative areas poised for business growth include the development of multiplexed luciferase assays that can simultaneously assess multiple biological parameters, and integration with AI-driven analytics platforms to enhance interpretation speed and accuracy. Lastly, the market is characterized by fast-paced technological advances, necessitating ongoing investment in R&D to maintain competitive advantage and address emerging needs in personalized medicine and high-throughput screening.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Luciferase Assays Market

The Luciferase Assays Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increased application in molecular biology and genetic engineering
    • Technological development to permit the quantitative visualization of gene expression in real time
    • Growing investment in research and government support
  • Market Restraints
    • Necessity for molecular oxygen to generate luminescence
  • Market Opportunities
    • Growing uses in beverage industry to check microbial contamination
    • Strategic collaboration between players
  • Market Challenges
    • Associated technical issues

Porter's Five Forces: A Strategic Tool for Navigating the Luciferase Assays Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Luciferase Assays Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Luciferase Assays Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Luciferase Assays Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Luciferase Assays Market

A detailed market share analysis in the Luciferase Assays Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Luciferase Assays Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Luciferase Assays Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Luciferase Assays Market

A strategic analysis of the Luciferase Assays Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Luciferase Assays Market, highlighting leading vendors and their innovative profiles. These include AAT Bioquest, Inc., Abcam PLC, Active Motif, Inc., Biotium, GeneCopoeia, Inc., Gold Biotechnology, Invivogen, Lonza Group AG, Merck KGaA, Molecular Devices, LLC, Novus Biologicals, OriGene Technologies, Inc., OZ Biosciences, Perkin Elmer, Inc., Promega Corporation, PromoCell GmbH, SwitchGear Genomics, Inc., Takara Bio Inc., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Luciferase Assays Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Method, market is studied across Dual Reporter Assay, Flash Assay, Glow Assay, and Single Reporter Assay.
  • Based on Application, market is studied across Gene Expression, Metabolic Activity, Protein-Protein Interaction, and Post-Translational Modification.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased application in molecular biology and genetic engineering
      • 5.1.1.2. Technological development to permit the quantitative visualization of gene expression in real time
      • 5.1.1.3. Growing investment in research and government support
    • 5.1.2. Restraints
      • 5.1.2.1. Necessity for molecular oxygen to generate luminescence
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing uses in beverage industry to check microbial contamination
      • 5.1.3.2. Strategic collaboration between players
    • 5.1.4. Challenges
      • 5.1.4.1. Associated technical issues
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Luciferase Assays Market, by Method

  • 6.1. Introduction
  • 6.2. Dual Reporter Assay
  • 6.3. Flash Assay
  • 6.4. Glow Assay
  • 6.5. Single Reporter Assay

7. Luciferase Assays Market, by Application

  • 7.1. Introduction
  • 7.2. Gene Expression
  • 7.3. Metabolic Activity
  • 7.4. Protein-Protein Interaction
  • 7.5. Post-Translational Modification

8. Americas Luciferase Assays Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Luciferase Assays Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Luciferase Assays Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AAT Bioquest, Inc.
  • 2. Abcam PLC
  • 3. Active Motif, Inc.
  • 4. Biotium
  • 5. GeneCopoeia, Inc.
  • 6. Gold Biotechnology
  • 7. Invivogen
  • 8. Lonza Group AG
  • 9. Merck KGaA
  • 10. Molecular Devices, LLC
  • 11. Novus Biologicals
  • 12. OriGene Technologies, Inc.
  • 13. OZ Biosciences
  • 14. Perkin Elmer, Inc.
  • 15. Promega Corporation
  • 16. PromoCell GmbH
  • 17. SwitchGear Genomics, Inc.
  • 18. Takara Bio Inc.
  • 19. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. LUCIFERASE ASSAYS MARKET RESEARCH PROCESS
  • FIGURE 2. LUCIFERASE ASSAYS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. LUCIFERASE ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. LUCIFERASE ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. LUCIFERASE ASSAYS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. LUCIFERASE ASSAYS MARKET DYNAMICS
  • TABLE 7. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY DUAL REPORTER ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY FLASH ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY GLOW ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY SINGLE REPORTER ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY GENE EХPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY METABOLIC ACTIVITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY PROTEIN-PROTEIN INTERACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL LUCIFERASE ASSAYS MARKET SIZE, BY POST-TRANSLATIONAL MODIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES LUCIFERASE ASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM LUCIFERASE ASSAYS MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM LUCIFERASE ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. LUCIFERASE ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 104. LUCIFERASE ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023